NCT00956306View on ClinicalTrials.gov

A Pharmacokinetic Study of Udenafil in Adult Subjects With or Without Impaired Hepatic Function

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Hepatic Impairment
Interventions
DRUG

Udenafil

100mg Single Oral Dose of Udenafil

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Dong-A Pharmaceutical Co., Ltd.

INDUSTRY